跳至主要内容
临床试验/CTRI/2024/06/069125
CTRI/2024/06/069125尚未招募4 期

TO STUDY AND COMPARE THE EFFECTIVENESS OF ORAL TOFACITINIB PLUS ORAL PUVASOL VS ORAL CORTICOSTEROIDS PLUS ORAL PUVASOL IN VITILIGO - A RANDOMIZED CONTROL TRIAL. - NO TRIAL ACRONYM

SUPRIYA BEHERA0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age more than 18 years
  • 2. Body surface area less than 80%
  • 3. Progressive disease( peak of incidence within 6 months )

排除标准

  • 1. Universal vitiligo
  • 2. Pregnant and lactating women
  • 3. Patients undergoing immunosuppressive therapy
  • 4. Patients of leukoderma due to other causes
  • 5. Patients having photosensitivity
  • 6. Patients having malignancy or undergone radiotherapy.

研究者

发起方
SUPRIYA BEHERA

相似试验

To compare the effects of oral tofacitinib plus oral... | 临床试验